Latest Insider Transactions at Health Catalyst, Inc. (HCAT)
This section provides a real-time view of insider transactions for Health Catalyst, Inc. (HCAT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Health Catalyst, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Health Catalyst, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,677
-2.25%
|
$134,708
$4.58 P/Share
|
|
Mar 03
2025
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-4.52%
|
$30,100
$4.58 P/Share
|
|
Mar 03
2025
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,800
-2.73%
|
$43,200
$4.58 P/Share
|
|
Mar 03
2025
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,304
-2.61%
|
$29,216
$4.58 P/Share
|
|
Mar 03
2025
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,024
-4.92%
|
$36,096
$4.58 P/Share
|
|
Mar 03
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,232
-3.81%
|
$36,928
$4.58 P/Share
|
|
Mar 01
2025
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
3,033
+3.99%
|
-
|
|
Mar 01
2025
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
2,450
+3.32%
|
-
|
|
Feb 20
2025
|
Benjamin Landry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
111,038
+21.68%
|
-
|
|
Feb 20
2025
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
192,950
+22.22%
|
-
|
|
Feb 20
2025
|
Kevin Lee Freeman Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
158,262
+15.75%
|
-
|
|
Feb 20
2025
|
Daniel D. Burton Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
371,437
+11.0%
|
-
|
|
Feb 20
2025
|
Daniel Le Sueur Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
156,340
+21.51%
|
-
|
|
Feb 20
2025
|
Linda Llewelyn Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,750
+18.71%
|
-
|
|
Feb 18
2025
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
6,441
-6.98%
|
$32,205
$5.43 P/Share
|
|
Feb 05
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-5.71%
|
$26,045
$5.76 P/Share
|
|
Jan 15
2025
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
6,442
-6.53%
|
$32,210
$5.8 P/Share
|
|
Jan 06
2025
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
2,500
-3.34%
|
$17,500
$7.52 P/Share
|
|
Jan 06
2025
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-5.4%
|
$36,463
$7.51 P/Share
|
|
Dec 30
2024
|
Duncan Gallagher |
SELL
Open market or private sale
|
Direct |
4,500
-6.05%
|
$27,000
$6.93 P/Share
|
|
Dec 23
2024
|
Duncan Gallagher |
SELL
Open market or private sale
|
Direct |
4,500
-5.7%
|
$27,000
$6.98 P/Share
|
|
Dec 16
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
6,442
-6.13%
|
$45,094
$7.88 P/Share
|
|
Dec 06
2024
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
19,268
-21.05%
|
$154,144
$8.32 P/Share
|
|
Dec 06
2024
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19,599
-18.44%
|
$156,792
$8.32 P/Share
|
|
Dec 04
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
22,773
-19.1%
|
$159,411
$7.7 P/Share
|
|
Dec 02
2024
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-3.07%
|
$60,000
$8.94 P/Share
|
|
Dec 01
2024
|
Green Jill Hoggard |
BUY
Grant, award, or other acquisition
|
Direct |
27,706
+50.0%
|
-
|
|
Dec 01
2024
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
1,616
+2.29%
|
-
|
|
Dec 01
2024
|
Anita Pramoda |
BUY
Grant, award, or other acquisition
|
Direct |
1,847
+3.08%
|
-
|
|
Dec 01
2024
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,766
-6.88%
|
$62,128
$8.97 P/Share
|
|
Dec 01
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,455
-8.06%
|
$83,640
$8.97 P/Share
|
|
Dec 01
2024
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30,897
-2.67%
|
$247,176
$8.97 P/Share
|
|
Dec 01
2024
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,419
-9.33%
|
$75,352
$8.97 P/Share
|
|
Dec 01
2024
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,431
-4.47%
|
$91,448
$8.97 P/Share
|
|
Dec 01
2024
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,795
-6.83%
|
$62,360
$8.97 P/Share
|
|
Dec 01
2024
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
2,001
+2.47%
|
-
|
|
Nov 15
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,365
-1.19%
|
$10,920
$8.5 P/Share
|
|
Nov 05
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-3.86%
|
$36,463
$7.7 P/Share
|
|
Oct 15
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,324
-1.15%
|
$10,592
$8.16 P/Share
|
|
Oct 03
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,209
-3.72%
|
$36,463
$7.68 P/Share
|
|
Sep 16
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,324
-1.13%
|
$10,592
$8.43 P/Share
|
|
Sep 06
2024
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,899
-2.48%
|
$20,293
$7.39 P/Share
|
|
Sep 06
2024
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
2,466
-2.38%
|
$17,262
$7.39 P/Share
|
|
Sep 04
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,137
-5.49%
|
$56,959
$7.58 P/Share
|
|
Sep 03
2024
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,165
-0.99%
|
$8,155
$7.27 P/Share
|
|
Sep 03
2024
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,613
-1.36%
|
$11,291
$7.27 P/Share
|
|
Sep 03
2024
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,174
-0.36%
|
$29,218
$7.27 P/Share
|
|
Sep 03
2024
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.85%
|
$52,500
$7.22 P/Share
|
|
Sep 03
2024
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,772
-1.04%
|
$19,404
$7.27 P/Share
|
|
Sep 03
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,761
-1.17%
|
$12,327
$7.27 P/Share
|